Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 186

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy

Open access
Wang, Meng, Han, Dong, Yuan, Ziming, Hu, Hanqing, Zhao, Zhixun, Yang, Runkun, Jin, Yinghu, Zou, Chaoxia, Chen, Yinggang, Wang, Guiyu, Gao, Xu, Wang, Xishan · 2018 · Cell Death & Disease

Abstract

Chemotherapy failure is the major cause of recurrence and poor prognosis in colorectal cancer (CRC) patients. The role of the differentially expressed lncRNAs in 5-Fluorouracil chemoresistance has not fully explained. Here, we observed lncRNA H19 was associated with the 5-Fu resistance in CRC. Quantitative analysis indicated that H19 was significantly increased in recurrent CRC patient samples. Kaplan–Meier survival analysis indicated that high H19 expression in CRC tissues was significantly associated with poor recurrent free survival. Our functional studies demonstrated that H19 promoted colorectal cells 5-Fu resistance. Mechanistically, H19 triggered autophagy via SIRT1 to induce cancer chemoresistance. Furthermore, bioinformatics analysis showed that miR-194–5p could directly bind to H19, suggesting H19 might work as a ceRNA to sponge miR-194–5p, which was confirmed by Dual-luciferase reporter assay and Immunoprecipitation assay. Extensively, our study also showed that SIRT1 is the novel direct target of miR-194–5p in CRC cells. Taken together, our study suggests that H19 mediates 5-Fu resistance in CRC via SIRT1 mediated autophagy. Our finding provides a novel mechanistic role of H19 in CRC chemoresistance, suggesting that H19 may function as a marker for prediction of chemotherapeutic response to 5-Fu.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-018-1187-4

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 35

  1. Marquez-Jurado, S. et al. Mitochondrial levels determine variability in cell death by modulating apoptotic gene expression. Nat. Commun. 9, 389 (2018). · DOI
  2. Longley, D. B., Allen, W. L. & Johnston, P. G. Drug resistance, predictive markers and pharmacogenomics in colorectal cancer. Biochim. Biophys. Acta 1766, 184–196 (2006).
  3. Zhang, J., Wang, P., Wan, L., Xu, S. & Pang, D. The emergence of noncoding RNAs as Heracles in autophagy. Autophagy 13, 1004–1024 (2017). · DOI
  4. Baek, S. H. & Kim, K. I. Epigenetic control of autophagy: Nuclear events gain more attention. Mol. Cell 65, 781–785 (2017). · DOI
  5. Morel, E. et al. Autophagy: A druggable process. Annu. Rev. Pharmacol. Toxicol. 57, 375–398 (2017). · DOI · Paper page
  6. Kopp, F. & Mendell, J. T. Functional Classification and Experimental Dissection of Long Noncoding RNAs. Cell 172, 393–407 (2018). · DOI · Paper page
  7. Han, D. et al. Long noncoding RNAs: novel players in colorectal cancer. Cancer Lett. 361, 13–21 (2015). · DOI · Paper page
  8. Xiong, X. D. et al. Long non-coding RNAs: An emerging powerhouse in the battle between life and death of tumor cells. Drug Resist. Updates : Rev. Comment. Antimicrob. Anticancer Chemother. 26, 28–42 (2016). · DOI
  9. Zhang, C. L., Zhu, K. P. & Ma, X. L. Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2. Cancer Lett. 396, 66–75 (2017). · DOI · Paper page
  10. Xiong, H. et al. LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells. Oncogene 36, 3528–3540 (2017). · DOI · Paper page
  11. Qu, L. et al. Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell. 29, 653–668 (2016). · DOI · Paper page
  12. Fanale, D., Castiglia, M., Bazan, V. & Russo, A. Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer. Adv. Exp. Med. Biol. 937, 207–228 (2016). · DOI
  13. Engemann, S. et al. Sequence and functional comparison in the Beckwith-Wiedemann region: implications for a novel imprinting centre and extended imprinting. Hum. Mol. Genet. 9, 2691–2706 (2000). · DOI
  14. Luo, M. et al. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett. 333, 213–221 (2013). · DOI · Paper page
  15. Berteaux, N. et al. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J. Biol. Chem. 280, 29625–29636 (2005). · DOI · Paper page
  16. Liang, W. C. et al. The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget 6, 22513–22525 (2015). · DOI · Paper page
  17. Ohtsuka, M. et al. H19 noncoding RNA, an independent prognostic factor, regulates essential Rb-E2F and CDK8-beta-catenin signaling in colorectal cancer. EBioMedicine 13, 113–124 (2016). · DOI
  18. Han, D. et al. Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3. Oncotarget 7, 22159–22173 (2016). · DOI · Paper page
  19. Li, J., Hou, N., Faried, A., Tsutsumi, S. & Kuwano, H. Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model. Eur. J. Cancer 46, 1900–1909 (2010). · DOI · Paper page
  20. Ou, X., Lee, M. R., Huang, X., Messina-Graham, S. & Broxmeyer, H. E. SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress. Stem Cells (Dayt., Ohio) 32, 1183–1194 (2014). · DOI · Paper page
  21. Zhang, Y. et al. Resveratrol enhances autophagic flux and promotes Ox-LDL degradation in HUVECs via upregulation of SIRT1. Oxid. Med. Cell Longev. 2016, 7589813 (2016). · DOI
  22. Jandura, A. & Krause, H. M. The new RNA world: Growing evidence for long noncoding RNA functionality. Trends Genet. : TIG 33, 665–676 (2017). · DOI · Paper page
  23. Li, J. H., Liu, S., Zhou, H., Qu, L. H. & Yang, J. H. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucl. Acids Res. 42, D92–D97 (2014). · DOI · Paper page
  24. Vennin, C. et al. The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications. Cancer Lett. 385, 198–206 (2017). · DOI
  25. Lin, J. et al. Arresting of miR-186 and releasing of H19 by DDX43 facilitate tumorigenesis and CML progression. Oncogene 37, 2432–2443 (2018). · DOI
  26. Zhang, L. et al. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis 34, 577–586 (2013). · DOI · Paper page
  27. Wang, Q. et al. Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma. Oncotarget 8, 2558–2567 (2017). · DOI
  28. Jiang, P. et al. Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy. Onco. Targets Ther. 9, 3501–3509 (2016).
  29. Kemp, M. G. Crosstalk between apoptosis and autophagy: Environmental genotoxins, infection, and innate immunity. J. Cell Death 9, 1179670716685085 (2017). · DOI
  30. Schiedel, M., Robaa, D., Rumpf, T., Sippl, W. & Jung, M. The current state of NAD(+) -dependent histone deacetylases (Sirtuins) as novel therapeutic targets. Med. Res. Rev. 38, 147–200 (2018). · DOI
  31. Oon, C. E., Strell, C., Yeong, K. Y., Ostman, A. & Prakash, J. SIRT1 inhibition in pancreatic cancer models: contrasting effects in vitro and in vivo. Eur. J. Pharmacol. 757, 59–67 (2015). · DOI
  32. Sun, L. N. et al. SIRT1 suppresses colorectal cancer metastasis by transcriptional repression of miR-15b-5p. Cancer Lett. 409, 104–115 (2017). · DOI
  33. Dell'Aversana, C. et al. miR-194-5p/BCLAF1 deregulation in AML tumorigenesis. Leukemia 31, 2315–2325 (2017). · DOI
  34. Miao, J. et al. miR-194 suppresses proliferation and migration and promotes apoptosis of osteosarcoma cells by targeting CDH2. Cell. Physiol. Biochem. : Int. J. Exp. Cell. Physiol., Biochem., Pharmacol. 45, 1966–1974 (2018). · doi:10.1159/000487973
  35. Hu, H. et al. Loss of ABCB4 attenuates the caspase-dependent apoptosis regulating resistance to 5-Fu in colorectal cancer. Biosci. Rep. 38, (2018). pii: BSR20171428 https://doi.org/10.1042/BSR20171428. · DOI

Cited by

See all 186

Metadata

Authors
Wang, M., Han, D., Yuan, Z., Hu, H., Zhao, Z., Yang, R., Jin, Y., Zou, C., Chen, Y., Wang, G., Gao, X., & Wang, X.
Venue
Cell Death & Disease
Published
2018-11-19
Volume
9
Issue
12
Pages
1149-1149
ISSN
2041-4889 (ISSN-L)
OpenAlex
W2901854772
Cited by
186
References
7
FWCI
5.89
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy. https://app.cochat.ai/papers/10.1038/s41419-018-1187-4
The paper
Wang, M., Han, D., Yuan, Z., Hu, H., Zhao, Z., Yang, R., Jin, Y., Zou, C., Chen, Y., Wang, G., Gao, X., & Wang, X. (2018). Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy. Cell Death & Disease. https://doi.org/10.1038/s41419-018-1187-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.